BRCA1 and triple-negative breast carcinoma: These results also correspond with findings by Nolan and colleagues who analyzed the tumor mutational burden by WES and found a marked enrichment of missense and indel mutations in BRCA1-mutated triple-negative breast cancer compared to the non-BRCA1-mutated group [41].